Wells Fargo & Company MN Increases Stock Position in Exponent, Inc. (NASDAQ:EXPO)

Share on StockTwits

Wells Fargo & Company MN increased its position in Exponent, Inc. (NASDAQ:EXPO) by 0.5% in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 172,776 shares of the business services provider’s stock after acquiring an additional 790 shares during the period. Wells Fargo & Company MN owned about 0.33% of Exponent worth $10,114,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in EXPO. Bremer Bank National Association purchased a new stake in Exponent during the 1st quarter valued at $55,000. NN Investment Partners Holdings N.V. purchased a new stake in shares of Exponent in the 2nd quarter worth $91,000. Cim LLC purchased a new stake in shares of Exponent in the 2nd quarter worth $200,000. Creative Planning purchased a new stake in shares of Exponent in the 1st quarter worth $208,000. Finally, Coldstream Capital Management Inc. purchased a new stake in shares of Exponent in the 1st quarter worth $210,000. Institutional investors own 88.11% of the company’s stock.

In other Exponent news, insider Harri Kytomaa sold 2,000 shares of the stock in a transaction dated Tuesday, August 13th. The shares were sold at an average price of $70.09, for a total transaction of $140,180.00. Following the completion of the transaction, the insider now owns 9,399 shares of the company’s stock, valued at approximately $658,775.91. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Richard L. Schlenker, Jr. sold 22,243 shares of the stock in a transaction dated Tuesday, August 20th. The shares were sold at an average price of $70.57, for a total transaction of $1,569,688.51. Following the transaction, the chief financial officer now directly owns 247,118 shares of the company’s stock, valued at approximately $17,439,117.26. The disclosure for this sale can be found here. Insiders sold a total of 102,773 shares of company stock valued at $7,227,536 in the last ninety days. 2.30% of the stock is currently owned by insiders.

Several equities research analysts have recently commented on the company. DA Davidson assumed coverage on Exponent in a research note on Wednesday, August 28th. They issued a “neutral” rating for the company. Zacks Investment Research raised shares of Exponent from a “hold” rating to a “strong-buy” rating and set a $76.00 target price for the company in a report on Monday, July 22nd. SunTrust Banks set a $70.00 target price on shares of Exponent and gave the stock a “buy” rating in a report on Friday, July 19th. ValuEngine raised shares of Exponent from a “sell” rating to a “hold” rating in a report on Wednesday, September 4th. Finally, BidaskClub downgraded shares of Exponent from a “buy” rating to a “hold” rating in a report on Tuesday. Four equities research analysts have rated the stock with a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus price target of $73.00.

Exponent stock traded up $1.23 during mid-day trading on Thursday, hitting $70.48. The stock had a trading volume of 4,358 shares, compared to its average volume of 203,935. The firm has a market capitalization of $3.60 billion, a P/E ratio of 56.09 and a beta of 0.43. The company has a current ratio of 3.60, a quick ratio of 3.60 and a debt-to-equity ratio of 0.05. The firm’s 50 day moving average is $69.57 and its 200 day moving average is $60.56. Exponent, Inc. has a one year low of $44.44 and a one year high of $72.15.

Exponent (NASDAQ:EXPO) last issued its earnings results on Thursday, July 18th. The business services provider reported $0.39 earnings per share for the quarter, topping the consensus estimate of $0.33 by $0.06. The company had revenue of $106.50 million during the quarter, compared to the consensus estimate of $95.77 million. Exponent had a net margin of 19.64% and a return on equity of 23.44%. Exponent’s quarterly revenue was up 11.4% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.34 EPS. As a group, equities research analysts forecast that Exponent, Inc. will post 1.47 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Friday, September 20th. Investors of record on Friday, September 6th will be issued a $0.16 dividend. This represents a $0.64 annualized dividend and a yield of 0.91%. The ex-dividend date of this dividend is Thursday, September 5th. Exponent’s dividend payout ratio is currently 51.20%.

Exponent Profile

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company worldwide. Its services include analysis of product development, product recall, regulatory compliance, and the discovery of potential problems related to products, people, property, and impending litigation.

Featured Article: Limitations of analyzing profit margin

Want to see what other hedge funds are holding EXPO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exponent, Inc. (NASDAQ:EXPO).

Institutional Ownership by Quarter for Exponent (NASDAQ:EXPO)

Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Assenagon Asset Management S.A. Invests $1.82 Million in Sientra Inc
Assenagon Asset Management S.A. Invests $1.82 Million in Sientra Inc
Assenagon Asset Management S.A. Sells 38,366 Shares of DSP Group, Inc.
Assenagon Asset Management S.A. Sells 38,366 Shares of DSP Group, Inc.
24,885 Shares in Neurocrine Biosciences, Inc.  Acquired by Assenagon Asset Management S.A.
24,885 Shares in Neurocrine Biosciences, Inc. Acquired by Assenagon Asset Management S.A.
Assenagon Asset Management S.A. Buys Shares of 38,711 AerCap Holdings
Assenagon Asset Management S.A. Buys Shares of 38,711 AerCap Holdings
141,908 Shares in Resources Connection, Inc.  Purchased by Assenagon Asset Management S.A.
141,908 Shares in Resources Connection, Inc. Purchased by Assenagon Asset Management S.A.
Pagerduty Inc  VP Sells $1,325,500.00 in Stock
Pagerduty Inc VP Sells $1,325,500.00 in Stock


© 2006-2019 Ticker Report